Ascendis Pharma A/S
ASND · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $559,543 | $392,164 | $444,767 | $446,267 |
| Short-Term Investments | $0 | $7,275 | $290,688 | $235,797 |
| Receivables | $166,280 | $35,874 | $11,910 | $2,200 |
| Inventory | $295,609 | $208,931 | $130,673 | $75,405 |
| Other Curr. Assets | $39,429 | $58,477 | $45,433 | $46,217 |
| Total Curr. Assets | $1,060,861 | $702,721 | $923,471 | $805,886 |
| Property Plant & Equip (Net) | $98,714 | $110,634 | $129,095 | $126,049 |
| Goodwill | $3,495 | $3,495 | $3,495 | $3,495 |
| Intangibles | $533 | $924 | $1,333 | $1,777 |
| Long-Term Investments | $13,575 | $5,686 | $30,424 | $145,906 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2,317 | $2,127 | $1,920 | $1,808 |
| Total NC Assets | $118,634 | $122,866 | $166,267 | $279,035 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,179,495 | $825,587 | $1,089,738 | $1,084,921 |
| Liabilities | – | – | – | – |
| Payables | $96,394 | $94,566 | $101,032 | $59,417 |
| Short-Term Debt | $491,536 | $435,443 | $426,768 | $13,990 |
| Tax Payable | $1,222 | $2,299 | $5,490 | $198 |
| Deferred Revenue | $936 | $1,184 | $0 | $2,601 |
| Other Curr. Liab. | $317,775 | $203,017 | $183,487 | $24,150 |
| Total Curr. Liab. | $907,863 | $736,509 | $716,777 | $100,356 |
| LT Debt | $365,080 | $307,615 | $190,800 | $195,932 |
| Deferred Rev, NC | $5,000 | $5,949 | $14,213 | $2,964 |
| Deferred Tax Liab, NC | $7,258 | $5,830 | $0 | $0 |
| Other NC Liab. | $0 | -$84,619 | -$95,400 | -$97,966 |
| Total NC Liab. | $377,338 | $234,775 | $109,613 | $100,930 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $98,793 | $109,191 | $104,961 |
| Total Liabilities | $1,285,201 | $971,284 | $826,390 | $201,286 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $8,149 | $7,749 | $7,675 | $7,646 |
| Retained Earnings | -$2,559,700 | -$2,277,095 | -$1,860,493 | -$1,235,508 |
| AOCI | $1,783 | $721 | $3,452 | $3,779 |
| Other Equity | $2,444,062 | $2,122,928 | $2,112,714 | $2,107,718 |
| Total Equity | -$105,706 | -$145,697 | $263,348 | $883,635 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,179,495 | $825,587 | $1,089,738 | $1,084,921 |
| Net Debt | $297,073 | $350,894 | $172,801 | -$236,345 |